# Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

> **NCT06036368** · NA · COMPLETED · sponsor: **Stimvia s.r.o.** · enrollment: 23 (actual)

## Conditions studied

- Parkinson's Disease
- Essential Tremor

## Interventions

- **DEVICE:** Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

## Key facts

- **NCT ID:** NCT06036368
- **Lead sponsor:** Stimvia s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-15
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036368, "Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06036368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*